Skip to main content

Table 1 Comparison of median AFP among groups of patient

From: Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology – a prospective study

Factor (number within brackets) AFP level (ng/ml) median and range P value
Gender (Males 343, 88.2%) Male 20 (1.16–100,000) Female 268 (3–26,172) 0.049
Macro vascular invasion (Present 110, 28.3%) Present 908 (1.16–100,000) Absent 12.6 (1.48–92,120) 0.002
Tumour diameter (<5 cm 176, 45.2%) <5 cm 11.5 (1.84–50,000) >5 cm 32 (1.16–94,120) 0.013
Stage (Early 196, 50.4%) Early 10.54 (1.48–50,000) (Stage I/II) Late 202 (1.16–100,000) (Sage III/IV) 0.001
Macroscopic tumour (Nodular 269, 69.1%) Nodular 9.6 (1.16–50,000) Diffuse 2308.5 (1.84–100,000) 0.002
Cirrhotic state (Cirrhotics 301, 77.4%) Cirrhotic 20.4 (1.48–10,000) Non cirrhotic 65 (1.16–94,120) 0.150
Alcohol consumption (Alcoholics −266, 68.4%) Alcoholic 26.6 (1.48–94,120) Non alcoholic 21 (1.16–100,000) 0.197
Diabetes mellitus (Diabetics 234, 60.1%) Diabetics 26.6 (1.48–100,000) Non diabetics 22 (1.16–94,120) 0.808
Child-Pugh (Class A - 223, 57.3%) Class A 12.33(1.66–94,120) Class B/C 26.03 (1.76–100,000) 0.179
Tumour nodularity (Single 199, 51.2%) Single 9.6 (1.16–50,000) Multiple 17.36 (1.85–94,120) 0.119